Dopamine agonists: effects of charged and uncharged analogues of dopamine.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1987-06-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM00384A038PMID 3806598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit

  2004cited by this paper
• N-substituted imidazolines and ethylenediamines and their action on alpha- and beta-adrenergic receptors.

  1985cited by this paper
• Dopamine receptors: Functions, subtypes and emerging concepts

  1985cited by this paper
• Dopaminergic agonists: comparative actions of amine and sulfonium analogues of dopamine.

  1984cited by this paper
• Synthesis, resolution, absolute stereochemistry, and enantioselectivity of 3',4'-dihydroxynomifensine.

  1984cited by this paper
• Synthesis and pharmacological evaluation of sulfonium analogues of dopamine: nonclassical dopamine agonists.

  1981cited by this paper
• In vitro acetylcholine release from rat caudate nucleus as a new model for testing drugs with dopamine-receptor activity

  1979cited by this paper
• Characteristics of the vascular dopamine receptor: comparison with other receptors.

  1978cited by this paper
• Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release.

  1974cited by this paper
• Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography

  1974cited by this paper

• A Three-Step, Gram-Scale Synthesis of Hydroxytyrosol, Hydroxytyrosol Acetate, and 3,4-Dihydroxyphenylglycol

  2019cites this paper
• Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines.

  2014cites this paper
• Addendum 2005–2008

  2011cites this paper
• Conjugate addition of sodium methanesulfinate to vinyl pyridines and diazines for the synthesis of aliphatic sulfones

  2009cites this paper
• Synthesis of 8-thiabicyclo[3.2.1]octanes and their binding affinity for the dopamine and serotonin transporters.

  2007cites this paper
• Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.

  2000cites this paper
• 2-Carbomethoxy-3-aryl-8-oxabicyclo[3.2.1]octanes: potent non-nitrogen inhibitors of monoamine transporters.

  1997cites this paper
• Syntheses and molecular structures of 3-N, N-di-n-propylamino-2-chromanones as new analogues of dopamine.

  1995cites this paper
• Cardioselective ammonium, phosphonium, and sulfonium analogues of alpha-tocopherol and ascorbic acid that inhibit in vitro and ex vivo lipid peroxidation and scavenge superoxide radicals.

  1995cites this paper
• Centrally acting dopamine D2 receptor ligands: agonists.

  1992cites this paper
• Isosterism and bioisosterism in drug design.

  1991cites this paper
• Structure-activity relationships in 1,4-benzodioxan-related compounds. 2. Role of the amine function on alpha-adrenoreceptor blocking activity.

  1990cites this paper
• Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.

  1989cites this paper
• Topography and conformational preferences of 6,7,8,9-tetrahydro-1-hydroxy-N,N-dipropyl-5H-benzocyclohepten-6- ylamin e. A rationale for the dopaminergic inactivity.

  1989cites this paper
• Inhibition of Prolactin Release from Anterior Pituitary Lactotrophs in Culture by Sulfur-Containing Analogs of Dopamine

  1988cites this paper
• Chapter 1. Antipsychotic Agents

  1988cites this paper
• Dopaminergic drugs in the cationic form interact with D2 dopamine receptors.

  1988cites this paper
• Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b ]-1,4-oxazin-7- and -9-ols: the significance of nitrogen pKa values for central dopamine receptor activation.

  1988cites this paper
• Dopamine D1 and D2 receptors are sensitive to the cationic form of apomorphine.

  1987cites this paper
• Charged analogues of chlorpromazine as dopamine antagonists.

  1987cites this paper